TR199902883T2 - NK-2 ve NK-3 reseptör antagonistleri olarak kuinolin-4-karboksamid türevleri. - Google Patents

NK-2 ve NK-3 reseptör antagonistleri olarak kuinolin-4-karboksamid türevleri.

Info

Publication number
TR199902883T2
TR199902883T2 TR1999/02883T TR9902883T TR199902883T2 TR 199902883 T2 TR199902883 T2 TR 199902883T2 TR 1999/02883 T TR1999/02883 T TR 1999/02883T TR 9902883 T TR9902883 T TR 9902883T TR 199902883 T2 TR199902883 T2 TR 199902883T2
Authority
TR
Turkey
Prior art keywords
quinoline
receptor antagonists
carboxamide derivatives
compounds
novel
Prior art date
Application number
TR1999/02883T
Other languages
English (en)
Inventor
Arnaldo Maria Giardina Giuseppe
Grugni Mario
Graziani Davide
Francesco Raveglia Luca
Original Assignee
Smithkline Beecham S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710750.2A external-priority patent/GB9710750D0/en
Priority claimed from IT002354 external-priority patent/IT1295358B1/it
Priority claimed from ITMI972775 external-priority patent/IT1296976B1/it
Application filed by Smithkline Beecham S.P.A. filed Critical Smithkline Beecham S.P.A.
Publication of TR199902883T2 publication Critical patent/TR199902883T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Abstract

Bu bulus, özellikle yeni kuinolin türevleri olmak üzere yeni bilesikler, bu gibi bilesiklerin hazirlanmasi için prosesler, bu gibi bilesikleri içeren farmasötik terkipler ve bu gibi terkiplerin tipta kullanimi ile ilgilidir. (Formül(I))
TR1999/02883T 1997-05-23 1998-05-18 NK-2 ve NK-3 reseptör antagonistleri olarak kuinolin-4-karboksamid türevleri. TR199902883T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9710750.2A GB9710750D0 (en) 1997-05-23 1997-05-23 Novel compounds
IT002354 IT1295358B1 (it) 1997-10-17 1997-10-17 Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3
ITMI972775 IT1296976B1 (it) 1997-12-16 1997-12-16 Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3

Publications (1)

Publication Number Publication Date
TR199902883T2 true TR199902883T2 (tr) 2000-05-22

Family

ID=27268859

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02883T TR199902883T2 (tr) 1997-05-23 1998-05-18 NK-2 ve NK-3 reseptör antagonistleri olarak kuinolin-4-karboksamid türevleri.

Country Status (26)

Country Link
EP (1) EP0983262B1 (tr)
JP (1) JP2002500645A (tr)
CN (1) CN1264378A (tr)
AP (1) AP9901695A0 (tr)
AR (1) AR012732A1 (tr)
AT (1) ATE244711T1 (tr)
AU (1) AU8209898A (tr)
BG (1) BG104009A (tr)
BR (1) BR9809652A (tr)
CA (1) CA2291111A1 (tr)
CO (1) CO4950515A1 (tr)
DE (1) DE69816290T2 (tr)
DZ (1) DZ2498A1 (tr)
EA (1) EA199901062A1 (tr)
ES (1) ES2201509T3 (tr)
HU (1) HUP0002300A3 (tr)
ID (1) ID22876A (tr)
IL (1) IL133036A0 (tr)
MA (1) MA26501A1 (tr)
NO (1) NO995711L (tr)
OA (1) OA11515A (tr)
PE (1) PE75199A1 (tr)
PL (1) PL336942A1 (tr)
SK (1) SK159299A3 (tr)
TR (1) TR199902883T2 (tr)
WO (1) WO1998052942A1 (tr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825554D0 (en) * 1998-11-20 1999-01-13 Smithkline Beecham Spa Novel Compounds
TR200101412T2 (tr) * 1998-11-20 2001-10-22 Smithkline Beecham S.P.A. Yeni bileşikler.
US6780875B2 (en) * 1998-11-20 2004-08-24 Smithkline Beecham S.P.A. Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
DE60004654T2 (de) 1999-03-29 2004-06-24 Neurogen Corp., Branford 4-substituierte chinolinderivate als nk-3 und/oder gaba(a) rezeptor liganden
AU4802500A (en) 1999-04-26 2000-11-10 Neurogen Corporation 2-aminoquinolinecarboxamides: neurokinin receptor ligands
AU2001276556A1 (en) * 2000-08-11 2002-02-25 Smithkline Beecham P.L.C. Novel pharmaceutical use of quinnoline derivatives
JP2004517062A (ja) * 2000-11-13 2004-06-10 グラクソスミスクライン・ソシエタ・ペル・アチオニ Ｎｋ−３およびｎｋ−２アンタゴニストとしてのキノリン誘導体
AU2002226356A1 (en) * 2000-11-28 2002-06-11 Glaxosmithkline S.P.A. Quinoline derivatives as nk-3 antagonists
GB0028964D0 (en) * 2000-11-28 2001-01-10 Smithkline Beecham Spa Novel compounds
US6540733B2 (en) 2000-12-29 2003-04-01 Corazon Technologies, Inc. Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion
EP1659120A1 (en) * 2001-04-11 2006-05-24 GlaxoSmithKline S.p.A. 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
GB0109122D0 (en) * 2001-04-11 2001-05-30 Smithkline Beecham Spa Novel compounds
MY134211A (en) * 2001-05-18 2007-11-30 Smithkline Beecham Corp Novel use
GB0425076D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
GB0425075D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
GB0425077D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
KR20080016591A (ko) * 2005-06-03 2008-02-21 아스트라제네카 아베 Ｎｋ3 길항제로서의 퀴놀린 유도체
GB0515580D0 (en) 2005-07-29 2005-09-07 Merck Sharp & Dohme Therapeutic compounds
AR057130A1 (es) 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
DE202007017299U1 (de) * 2007-12-12 2009-04-23 Drebo Werkzeugfabrik Gmbh Bohrer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ291476B6 (cs) * 1994-05-27 2003-03-12 Smithkline Beecham S. P. A. N-(alfa-Ethylbenzyl)-3-hydroxy-2-fenylchinolin-4-karboxamid, farmaceutický prostředek s jeho obsahem a použití
AR004735A1 (es) * 1995-11-24 1999-03-10 Smithkline Beecham Spa Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento.

Also Published As

Publication number Publication date
BR9809652A (pt) 2001-09-11
BG104009A (en) 2000-07-31
ES2201509T3 (es) 2004-03-16
MA26501A1 (fr) 2004-12-20
IL133036A0 (en) 2001-03-19
ATE244711T1 (de) 2003-07-15
CA2291111A1 (en) 1998-11-26
CO4950515A1 (es) 2000-09-01
DE69816290T2 (de) 2004-05-27
HUP0002300A3 (en) 2002-01-28
PL336942A1 (en) 2000-07-17
ID22876A (id) 1999-12-16
AR012732A1 (es) 2000-11-08
PE75199A1 (es) 1999-10-22
JP2002500645A (ja) 2002-01-08
EP0983262A1 (en) 2000-03-08
WO1998052942A1 (en) 1998-11-26
CN1264378A (zh) 2000-08-23
DZ2498A1 (fr) 2003-01-25
HUP0002300A2 (hu) 2001-06-28
SK159299A3 (en) 2000-06-12
AU8209898A (en) 1998-12-11
AP9901695A0 (en) 1999-12-31
NO995711D0 (no) 1999-11-22
EA199901062A1 (ru) 2000-08-28
NO995711L (no) 2000-01-19
DE69816290D1 (de) 2003-08-14
OA11515A (en) 2004-02-04
EP0983262B1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
TR199902883T2 (tr) NK-2 ve NK-3 reseptör antagonistleri olarak kuinolin-4-karboksamid türevleri.
TR199800883T2 (tr) Kuinolin-4-Karboksamid türevleri, hazirlanmalari ve nörokinin 3 (NK-3)- ve nörokinin 2 (NK-2) reseptör antagonistleri olarak kullanimlari.
TR200202288T2 (tr) Yeni indolin-2-on türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
TR200101412T2 (tr) Yeni bileşikler.
TR199801594A2 (tr) CCR-3 reseptör antagonistleri.
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
TR200201225T2 (tr) Heteosiklik ikameli pirazolonlar.
ATE267200T1 (de) Bicyclische kinase inhibitoren
NO20015226L (no) Tri-aryl syrederivater som PPAR reseptor ligander, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament.
FI980341A0 (fi) 2-oksi-indolijohdannaisia
TR199801041T2 (tr) Kanabinoid reseptör afinitesine sahip olan 3-pirazolkarboksamid türevleri.
ATE245644T1 (de) 1,3-dihydro-2h-indol-2-on derivate und deren verwendung als liganden der arginin-vasopressin rezeptoren v1b oder v1b und v1a
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
EA200100774A1 (ru) Гетероциклические производные с функциональными группами (варианты), фармацевтическая композиция и комбинация, способ модулирования активности рецептора хемокина (варианты), способ профилактики инфицирования вич и лечения инфекции вич, замедления проявления спид и лечения спид, способ лечения воспалительных процессов
ATE300541T1 (de) Pyrazolopyridinderivate
EA200200732A1 (ru) Замещенные производные фенилпиперазина, их получение и применение
EE05182B1 (et) Asendatud homopiperidlbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
WO2001029066A3 (en) Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
ATE274515T1 (de) Pyrazolopyridinderivate
SE9904128D0 (sv) Novel compounds
DE60222465D1 (de) Pyrazolopyridin-derivate als antiherpesmittel
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri